About: Alendronate inhibition of protein-tyrosine-phosphatase-meg1

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Alendronate inhibition of protein-tyrosine-phosphatase-meg1 Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 September 1997

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у вересні 1997 (uk) im September 1997 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en setiembre de 1997 (ast) scientific article published on 01 September 1997 (en)
publication date	wds:Q73731757-5973360C-F182-41A0-BD4C-243EDD62A82B
publication date	1997-09-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q73731757-2430DA5B-3FDE-4DCA-977F-E4A46098F68B
language of work or name	English
cites work	wds:Q73731757-0A36050E-7869-4A28-8A21-30CC52DDD0CF wds:Q73731757-20B42C1A-C701-4EE6-9100-152CBB974DFC wds:Q73731757-34A6C3EC-D485-411D-B1BE-A4249C49F13E wds:Q73731757-495ABD92-1A7D-4866-95A9-0E1E24CD8A5A wds:Q73731757-6CB55EA0-D2DD-4C53-8564-F3CB897CB5BE wds:Q73731757-7B8A5BF5-7232-4EE8-BD37-1E206167A81D wds:Q73731757-7B96F01A-2D78-407C-B080-A337B104BFDC wds:Q73731757-86C6FBC7-8CD0-4B3C-A896-EB0A2A0CE450 wds:Q73731757-98D06A25-E01B-4D52-9EF0-75981AFD334D wds:Q73731757-9B4AAD0B-038B-41CF-A60B-7C782733488A wds:Q73731757-A5B01CB2-F9C6-41E7-87AE-3BD13976C083 wds:Q73731757-BB04684D-452E-4DBD-96AA-DF275BC5763B wds:Q73731757-C1B8AF8B-75BD-4A27-B8CF-7F6241027F54 wds:Q73731757-DB9F428E-47E4-4D48-B4D4-5130BD065DD8 wds:Q73731757-DF40800A-7A09-4992-AF2B-46497DD62EA1 wds:Q73731757-EC3054DC-40DD-4941-8267-3C36D7FCA65D wds:Q73731757-F4DDDFD0-17F0-44E6-8A04-3FCE21BC006B wds:Q73731757-F789311E-5BEF-4A44-8E36-FA1EA68B1463 wds:Q73731757-F8EDD08D-F90F-4AAF-A22C-7E73DFAE133C
cites work	Bisphosphonates act on rat bone resorption through the mediation of osteoblasts Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow cultures. Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo. Comparison of the distribution of 3H-alendronate and 3H-etidronate in rat and mouse bones Characterization and kinetic analysis of the intracellular domain of human protein tyrosine phosphatase beta (HPTP beta) using synthetic phosphopeptides Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice Human protein tyrosine phosphatase-sigma: alternative splicing and inhibition by bisphosphonates Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding The coordinated action of protein tyrosine phosphatases and kinases in cell signaling Bisphosphonates: a review of their pharmacokinetic properties Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice Herbimycin A, a pp60c-src tyrosine kinase inhibitor, inhibits osteoclastic bone resorption in vitro and hypercalcemia in vivo Estimation of the initial velocity of enzyme-catalysed reactions by non-linear regression analysis of progress curves Amino acid phosphatase activity of alkaline phosphatase. A possible role of protein phosphatase Alendronate modulates osteogenesis of human osteoblastic cells in vitro Rationale for the use of alendronate in osteoporosis
author name string	wds:Q73731757-43A7D1AF-BDFB-4B75-93F9-75A273015365 wds:Q73731757-6CE7A0DF-1419-48BF-A3AB-7BA0B3B54908 wds:Q73731757-8AD16032-8CFB-452C-B49C-C9D8D48A2298 wds:Q73731757-C2C43DEB-9E5B-4249-982F-F2BE2FCF0203 wds:Q73731757-C40C5F41-D418-4522-B910-E768D78F9D1E wds:Q73731757-DAD741DA-1F96-4A15-9EBE-8CB4EB5B0E27 wds:Q73731757-F2EDAD0F-2365-4404-A020-76B42275E834
author name string	A Schmidt G A Rodan A Stern E Golub E E Opas S J Rutledge Z Zimolo
rdfs:label	Alendronate inhibition of protein-tyrosine-phosphatase-meg1 (en) Alendronate inhibition of protein-tyrosine-phosphatase-meg1 (nl)
skos:prefLabel	Alendronate inhibition of protein-tyrosine-phosphatase-meg1 (en) Alendronate inhibition of protein-tyrosine-phosphatase-meg1 (nl)
name	Alendronate inhibition of protein-tyrosine-phosphatase-meg1 (en) Alendronate inhibition of protein-tyrosine-phosphatase-meg1 (nl)
title	wds:Q73731757-1226C5F5-B750-4FD9-8BF1-DA23A9606B0B
title	Alendronate inhibition of protein-tyrosine-phosphatase-meg1 (en)
page(s)	wds:Q73731757-4518CBE1-E5DA-4FBD-8253-DC0485AABD76
page(s)	721-727
instance of	wds:Q73731757-B36CDDFD-52F5-420A-9A9F-AA3E71644B87
instance of	scholarly article
PubMed ID	wds:Q73731757-328904FD-18FE-43EF-98E4-EDAE2B09A130
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9310349
PubMed ID	9310349
published in	wds:Q73731757-BCA4D1CB-43ED-4197-95B8-BEBC0C35E0AA
published in	Biochemical Pharmacology
issue	wds:Q73731757-6E4BCA97-7997-4EC4-8991-CEDA6E0EAE57
volume	wds:Q73731757-3997A284-45BD-4535-A560-FD70941B62E8
issue	6
volume	54
DOI	wds:Q73731757-BCFF9161-FE5A-4680-A025-9FF43B2342F5
DOI	http://dx.doi.org/10.1016/S0006-2952(97)00225-6
DOI	10.1016/S0006-2952(97)00225-6
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73731757
is cites work of	Bisphosphonate mechanism of action Molecular mechanisms of action of bisphosphonates. Clodronate stimulates osteoblast differentiation in ST2 and MC3T3-E1 cells and rat organ cultures Drugs in development: bisphosphonates and metalloproteinase inhibitors Bisphosphonates: from the laboratory to the clinic and back again Pharmacokinetics of alendronate Tyrosine Phosphatase Epsilon Is a Positive Regulator of Osteoclast Function in Vitro and In Vivo Alendronate: an update of its use in osteoporosis Activation of Src kinase by protein-tyrosine phosphatase-PEST in osteoclasts: comparative analysis of the effects of bisphosphonate and protein-tyrosine phosphatase inhibitor on Src activation in vitro
is cites work of	wds:Q24795847-56BDB32E-220F-43F6-8692-6682D443BC1A wds:Q34786247-54D6EFC8-A884-4C20-8DC8-BA8315F7EAD1 wds:Q46058982-40CEEAE2-E0B2-490B-BC09-CD874A0258DC wds:Q33697467-C358328A-E2B8-4EEF-BA46-CF349E08CC61

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software